Publicatie

Publicatie datum

Protocol for a phase II, monocenter, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2, 3 and 4 (SPACE trial).

Stam, M., Wadman, R.I., Wijngaarde, C.A., Bartels, B., Asselman, F.L., Otto, L.A.M., Goedee, H.S., Habets, L.E., Groot, J.F. de, Schoenmakers, M.A., Cuppen, I., Berg, L.H. van den, Pol, W.L. van der. Protocol for a phase II, monocenter, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2, 3 and 4 (SPACE trial). BMJ Open: 2018, 8(7), e019932
Lees online